Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2001-03-14 | Mr. Uhrhan has been a Director of the Company since 1997. Mr. Uhrhan's principal occupation has been that of Vice President Finance of Solvay America, Inc., a chemical and pharmaceuticals company, since 1996. He also serves as a Director of Duramed Pharmaceuticals, Inc. Mr. Uhrhan was a Partner with Ernst & Young LLP for more than five years prior to his employment by Solvay America, Inc. ... The Company's audit committee, composed of independent directors Messrs. Langford, Howard and Uhrhan, held three meetings during 2000, and all members attended all meetings, except Mr. Uhrhan who attended one meeting. ... Non-employee directors are paid a fee of $1,000 per month, participate in an incentive bonus program similar to the bonus program described in the Compensation Committee Report and participate in the Amended and Restated 1997 Stock Option Plan. Incentive bonuses paid to directors are based on the Company's performance and profitability. In 2000, each director received a bonus of $6,180 in addition to the monthly fee. |
| 2002-03-18 | Philip Uhrhan Director since 1997 (vice president finance, Solvay America, Inc.) ... The Company's audit committee, composed of independent directors Messrs. Langford, Howard and Uhrhan, held three meetings during 2001. ... Philip Uhrhan, Chairman ... Compensation to directors Non-employee directors are paid a fee of $1,000 per month, participate in an incentive bonus program similar to the bonus program described in the Compensation Committee Report and participate on a one-time basis in the Amended and Restated 1997 Stock Option Plan. In 2001, the Company was not profitable; thus the directors did not receive a bonus for 2001. In 2000, each director received a bonus of $6,180 in addition to the monthly fee. |
| 2003-03-13 | Mr. Uhrhan has been a Director of the Company since 1997. Mr. Uhrhan's principal occupation has been that of Vice President - Finance of Solvay America, Inc., a chemical and pharmaceuticals company, since 1996. The Company's audit committee, composed of independent directors Messrs. Langford, Howard and Uhrhan, held three meetings during 2002. Compensation to directors Non-employee directors are paid a fee of $1,000 per month, participate in an incentive bonus program similar to the bonus program described in the Compensation Committee Report and participate on a one-time basis in the Amended and Restated 1997 Stock Option Plan. Incentive bonuses paid to directors are based on the Company's performance and profitability. In 2002, the Company was not profitable; thus the directors did not receive a bonus for 2002. |
| 2004-03-17 | Philip Uhrhan Age: 54 Role: Director Committees: Audit Committee (Chairman) Compensation: $1,000 per month fee until October 2003, reduced by 15% in November 2003 Excerpt: "The Company9s audit committee, composed of independent directors Messrs. Langford, Howard and Uhrhan, held three meetings during 2003." |
| 2005-04-11 | Mr. Uhrhan’s principal occupation has been that of Vice President–Finance of Solvay America, Inc., a chemical and pharmaceuticals company. |
Data sourced from SEC filings. Last updated: 2025-07-01